Carter Gould

Q: What is Carter Gould's success rate?

Carter Gould currently has a success rate of 88.70098349587124.

Q: What is the average return of Carter Gould's calls?

Their stock ratings have generated an average return of 13.844814838833651.

Cantor Fitzgerald | Healthcare

Carter Gould is an analyst from Cantor Fitzgerald specializing in the Healthcare sector. Ranked #1432 out of 4771 analysts, they have issued 33 stock ratings with a success rate of 88.70% and an average return of 13.84%.

Carter Gould has a well-established track record, with 33 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 88.70% and an average return of 13.84%, underscoring their expertise and ability to identify winning opportunities for investors.

#1432

Out of 4771

Total Ratings

+88.70%

Success Rate

+13.84%

Average Return

Recent Ratings Analysis

GILD

Buy

Aug 05, 2026

Target

$155.00

Current

$144.81

Performance

9.90%

Carter Gould rated GILD as Overweight on Aug 05, 2026, setting a price target of 155. The call has proven timely, with shares rising 9.90% toward the price target of 155.

VRTX

Buy

Aug 04, 2026

Target

$595.00

Current

$514.56

Performance

7.49%

On Aug 04, 2026, VRTX was given a Overweight rating by Carter Gould, with a target price of 595. The stock rallied 7.49% after the rating, narrowing the gap to the target of 595 and validating the bullish stance.

ABBV

Buy

Aug 03, 2026

Target

$285.00

Current

$254.98

Performance

4.04%

ABBV received a Overweight rating from Carter Gould on Aug 03, 2026, aiming for 285. Price action was muted, as shares hovered around 254.98 despite the bullish outlook.

BMY

Hold

Jul 31, 2026

Target

$59.00

Current

$63.75

Performance

-2.39%

On Jul 31, 2026, Carter Gould published a Neutral outlook on BMY, with a target of 59. Sideways action left the Hold view intact, with no major move since 63.75.

REGN

Buy

Jul 31, 2026

Target

$795.00

Current

$793.26

Performance

4.02%

Carter Gould on Jul 31, 2026 assigned REGN a Overweight rating, with a price target of 795. The recommendation remains pending validation as shares consolidate around 793.26.

MRK

Hold

Jul 06, 2026

Target

$120.00

Current

$144.71

Performance

14.14%

On Jul 06, 2026, Carter Gould reaffirmed MRK with a Neutral rating, targeting 120. Market strength beyond 144.71 went further than the conservative outlook suggested.

AMGN

Hold

Jul 06, 2026

Target

$350.00

Current

$382.47

Performance

4.37%

AMGN was rated Neutral by Carter Gould on Jul 06, 2026, with a price objective of 350. Flat performance suggests the Hold view was reasonable.

LLY

Buy

Jul 06, 2026

Target

$1350.00

Current

$1123.04

Performance

-6.42%

On Jul 06, 2026, Carter Gould initiated coverage on LLY with a Overweight rating and target of 1350. The Buy call has yet to be validated as shares remain 226.96 away from the target.

PFE

Hold

Jul 06, 2026

Target

$27.00

Current

$27.65

Performance

16.57%

Carter Gould issued a Neutral recommendation for PFE on Jul 06, 2026, price target set at 27. A neutral call gave way to stronger-than-expected performance, closing in on 27.

NUVL

Buy

Oct 31, 2025

Target

$112.00

Current

$123.96

Performance

24.81%

On Oct 31, 2025, NUVL was evaluated by Carter Gould, who gave a Overweight rating and target of 112. This case illustrates how a timely bullish rating can translate into tangible gains of 24.81%.

NBIX

Buy

Dec 23, 2024

Target

$165.00

Current

$156.57

Performance

14.29%

Carter Gould rated NBIX as Overweight on Dec 23, 2024, setting a price target of 165. The call has proven timely, with shares rising 14.29% toward the price target of 165.

TVTX

Buy

Oct 01, 2024

Target

$18.00

Current

$67.51

Performance

382.56%

On Oct 01, 2024, TVTX was given a Overweight rating by Carter Gould, with a target price of 18. The stock rallied 382.56% after the rating, narrowing the gap to the target of 18 and validating the bullish stance.

VOR

Buy

Aug 14, 2024

Target

$3.00

Current

$22.34

Performance

35.39%

VOR received a Overweight rating from Carter Gould on Aug 14, 2024, aiming for 3. Momentum has favored the Buy call, with shares climbing from 22.34 to 22.34, rewarding those who trusted the recommendation.

BIIB

Hold

Aug 02, 2024

Target

$190.00

Current

$215.43

Performance

4.75%

On Aug 02, 2024, Carter Gould published a Equal-Weight outlook on BIIB, with a target of 190. Sideways action left the Hold view intact, with no major move since 215.43.

Frequency Asked Questions

Who is Carter Gould?

Carter Gould is an analyst from Cantor Fitzgerald specializing in the Healthcare sector.

What is Carter Gould's success rate?

Carter Gould currently has a success rate of +88.70%.

How many ratings has Carter Gould issued?

Carter Gould has issued 33 stock ratings so far.

What is the average return of Carter Gould's calls?

Their stock ratings have generated an average return of +13.84%.

What is Carter Gould's ranking?

Carter Gould is ranked #1432 out of 4771 analysts.

What types of ratings does Carter Gould give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Carter Gould?

You can follow Carter Gould by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Carter Gould?

Their latest rating was a Buy on GILD issued on 2026-08-05.